Novavax
NVAX
#4816
Rank
A$3.00 B
Marketcap
A$18.25
Share price
15.80%
Change (1 day)
37.52%
Change (1 year)

Novavax (NVAX) - Total debt

Total debt on the balance sheet as of June 2026 : A$0.42 Billion

According to Novavax's latest financial reports the company's total debt is A$0.42 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Novavax - Total debt on balance sheet (from 1999 to 2026)

Total debt by year

Year Total debt Change
2025-12-31A$0.37 B0.28%
2024-12-31A$0.37 B10.17%
2023-12-31A$0.33 B-58.38%
2022-12-31A$0.80 B29.01%
2021-12-31A$0.62 B2.89%
2020-12-31A$0.60 B32.39%
2019-12-31A$0.45 B1.47%
2018-12-31A$0.45 B11.32%
2017-12-31A$0.40 B-7.25%
2016-12-31A$0.43 B80837.61%
2015-12-31A$0.54 M-55.54%
2014-12-31A$1.21 M-42.17%
2013-12-31A$2.1 M81.86%
2012-12-31A$1.15 M271.54%
2011-12-31A$0.31 M-20.75%
2010-12-31A$0.39 M-27.21%
2009-12-31A$0.54 M-98.33%
2008-12-31A$32.46 M24.79%
2007-12-31A$26.02 M-11.55%
2006-12-31A$29.41 M-29.5%
2005-12-31A$41.72 M-13.12%
2004-12-31A$48.02 M-15.34%
2003-12-31A$56.72 M-22.81%
2002-12-31A$73.48 M9.23%
2001-12-31A$67.28 M88.09%
2000-12-31A$35.77 M23405.79%
1999-12-31A$0.15 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Novartis
NVS
A$70.14 B 16,385.32%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$90.43 B 21,154.61%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$46.13 B 10,743.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$34.58 B 8,028.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
A$1.49 B 251.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A$7.01 M-98.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$58.25 M-86.31%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
A$2.14 M-99.50%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A$1.13 B 166.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.83 B 95.68%๐Ÿ‡บ๐Ÿ‡ธ USA